期刊文献+

低分子肝素联合小剂量阿司匹林对子痫前期高危人群的预防效果分析 被引量:21

Preventing Effect of Low Molecular Heparin and Low-dose Aspirin on Preeclampsia in High-risk Group
下载PDF
导出
摘要 目的探讨低分子肝素(LMWH)联合小剂量阿司匹林(LDA)对子痫前期(PE)高危人群的预防效果。方法将笔者医院妇产科收治的94例PE高危人群随机分为对照组(n=31)、肝素组(n=31)和联合组(n=32)。肝素组皮下注射LMWH5000IU,联合组在肝素组基础上,加用阿司匹林75mg/d。比较PE的发生率、APTT与24h尿蛋白量的变化以及妊娠结局。结果肝素组、联合组PE的发生率较对照组明显降低(P<0.05),联合组重度PE的发生率显著低于肝素组(P<0.05)。与对照组比较,治疗后肝素组、联合组24h尿蛋白明显降低,APTT明显延长,且联合组24h尿蛋白明显低于肝素组(P<0.05);与对照组比较,肝素组、联合组早产、胎儿生长迟缓、胎盘早剥、新生儿窒息的发生率明显降低,新生儿出生体重明显升高,联合组胎盘早剥的发生率明显低于肝素组,新生儿出生体重明显高于肝素组(P<0.05)。结论 PE高危人群给予LDA联合LMWH可一定程度降低PE的发生风险和妊娠并发症,改善妊娠结局。 Objective To explore the preventing effect of low molecular heparin (LWMH) and low - dose aspirin(LDA) for pre- eclampsia (PE) in high -risk group. Methods Totally 94 PE in high -risk group who were admitted in obstetrics and gynecology de- partment of our hospital were divided into three groups. LWMH group(n = 31 ) was given LWMH subcutaneous injection for 5000 IU, combined group was given aspirin for 75 mg/d, additionally. The incidence of PE, change of APTT and 24 - hour urine protein, and pregnancy outcome, were compared Results The incidence of PE in LWMH group and combined group was significantly lower than that in control group( P 〈 0.05 ) , and combined group was significant lower than LWMH group( P 〈 0.05 ). Compared with control group, the 24 - hour urine protein in LWMH group and combined group was remarkably reduced, APTT was increased, and the 24 - hour urine pro- tein in combined group was significantly lower than that in LWMH group(P 〈 0.05). Compared with control group, the incidence of pre- mature delivery, intrauterine growth retardation, abruptio placentae, neonatal asphyxia in LWMH group and combined group was remark- ably reduced, neonate birth weight was increased ( P 〈 0.05 ). The abruptio placentae in combined group was significantly lower, neonate birth weight was higher than that in LWMH group(P 〈 0.05). Conclusion LDA combined with LMWH for PE in high - risk group can on some degree reduce the risk of PE and pregnancy complications, and improve the pregnancy outcome.
出处 《医学研究杂志》 2016年第12期119-121,共3页 Journal of Medical Research
关键词 子痫前期 高危人群 低分子肝素 阿司匹林 Preeclampsia High - risk group Low molecular heparin Aspirin
  • 相关文献

参考文献4

二级参考文献105

  • 1林其德.子癎前期子癎病因及发病机制的研究进展[J].中国实用妇科与产科杂志,2004,20(10):577-579. 被引量:71
  • 2胡乔飞,李坚.遗传性血栓形成倾向与反复自然流产的研究进展[J].生殖与避孕,2006,26(10):610-617. 被引量:17
  • 3蒋敏,秦卫兵,王一峰,张敏,刘娜,黄淑洪.抗心磷脂抗体阳性复发性流产患者肝素治疗的抗凝监测[J].实用医学杂志,2007,23(11):1668-1669. 被引量:4
  • 4Kupfermine MJ. Thrombophilia and preeclampsia: the evidence so far[J]. Clin Obstet Gyneeol , 2005,48:406-415.
  • 5Brenner B, Bar J, Ellis M, et al. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study[ J]. Fertil Steril,2005, 84:770-773.
  • 6Kalk JJ,Huisjes AJ, de Groot CJ. et al. Recurrence rate ofpreeclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? [ J]. Neth J Med, 2004, 62 ( 3 ) :83-87.
  • 7Nakabayashi M, Asami M, Nakatani A. Efficacy of antithrombin replacement therapy in severe early-onset preeclampsia [J]. Semin Thromb Hemost, 1999,25 ( 5 ) :463-466.
  • 8Hiroshi S, Yuki K, Tsuyomu I, et al. Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation : a randomized, double-blind, placebo-controlled trial[J]. J Obstet Gynaecol Res,2008 ,34 :34-39.
  • 9Zeev B, Benjamin B. Thrombophilia-associated pregnancy wastage [ J ]. Fertil Steril, 1999,5 ( 72 ) : 765-774.
  • 10Saisto T,Tiitinen A, Ulander VM, et al. Clinical cure of severe, early onset pre-eclampsia with low molecular weight heparin therapy in primigravida with hyperreaction luteinalis and thrombophilia [J]. Human Reprod,2004, 19(3) :725-728.

共引文献1259

同被引文献141

引证文献21

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部